Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
2,918,442
-
Share change
-
+47,493
-
Total reported value
-
$4,902,496
-
Price per share
-
$1.68
-
Number of holders
-
22
-
Value change
-
+$70,569
-
Number of buys
-
7
-
Number of sells
-
11
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q1 2025
As of 31 Mar 2025,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,918,442 shares.
The largest 10 holders included
Bleichroeder LP, Cable Car Capital, LP, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, MORGAN STANLEY, SUSQUEHANNA INTERNATIONAL GROUP, LLP, STATE STREET CORP, Private Advisor Group, LLC, and TOCQUEVILLE ASSET MANAGEMENT L.P..
This page lists
22
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.